ALPHA PSYCHIATRY
Original Articles

May BPA and phthalates have a role in etiopathogenesis of ADHD?

1.

Department of Department of Psycology, Gelisim University, Istanbul, Turkey

2.

Department of Child and Adolescent Psychiatry, Erciyes University School of Medicine, Kayseri, Turkey

3.

Department of Social Pediatrics, Erciyes University School of Medicine, Kayseri, Turkey

4.

Department of Pediatric Metabolism, Erciyes University School of Medicine, Kayseri, Turkey

5.

Department of Pediatric Neurology, Erciyes University School of Medicine, Kayseri, Turkey

Alpha Psychiatry 2018; 19: 300-306
DOI: 10.5455/apd.280093
Read: 821 Downloads: 456 Published: 01 June 2018

Objective: Although the etiology ofattention deficit hyperactivity disorder (ADHD) is unknown, it is thought that endocrine disruptors may be involved in the etiopathogenesis. The aim of this study was to investigate the relation-ship between ADHD development and exposure to mono-(2-ethylhexyl) phthalate (MEHP), di-(2-ethylhexyl) phtha-late (DEHP), and bisphenol A (BPA). Methods: The study included 44 children who were diagnosed with ADHD according to DSM IV-TR diagnostic criteria and 51 healthy children as controls. In all subjects, serum MEHP, DEHP, and BPA were measured by using high performance liquid chromatography (HPLC). Results: Serum MEHP and BPA levels were found to be significantly higher in the ADHD group (0.47±0.22 µg/ml, 1.48±0.28 ng/ml) than the controls (0.31±0.13 µg/ml, 0.91±0.23 ng/ml). There was no difference in the level of DEHP between the ADHD group and healthy controls (2.17±0.69 µg/ml, 2.26±0.56 µg/ml). Conclusion: Our results could be accepted as an evidence to support an association between BPA, MEHPlevels and ADHD. However, further studies are needed to clarify the linkage between ADHD and endocrine disruptors. [Anadolu Psikiyatri Derg 2018; 19(3.000): 300-306]

Files
EISSN 2757-8038